Literature DB >> 22021061

Adverse effects of iodine thyroid blocking: a systematic review.

L Spallek1, L Krille, C Reiners, R Schneider, S Yamashita, H Zeeb.   

Abstract

(131)I, when released in a radiological or nuclear accident as happened recently in Fukushima, Japan, may cause thyroid cancer as a long-term consequence. Iodine thyroid blocking (ITB) is known to reduce the risk of developing thyroid cancer. Potential adverse effects of ITB have not been systematically investigated so far. This article summarises the results of a review on adverse effects of ITB based on a systematic literature search in scientific medical databases. A meta-analysis was not performed as identified studies displayed major heterogeneity. The search resulted in 14 articles relevant to the topic, reporting mostly on surveys, ecological and intervention studies. Only one study from Poland focused on effects (both desired and adverse) of an ITB intervention following the Chernobyl accident. All other studies reported on iodine administration in a different context. Overall, the studies did not reveal severe adverse reactions to potassium iodide in the general public. Since ITB is a protective measure only applied in very specific circumstances, scientifically sound studies of adverse effects are scarce and consequently the evidence base is weak. The assessment of adverse effects of ITB relies on indirect evidence from related areas. This study may contribute to ongoing developments in pharmacoepidemiology aiming to better quantify adverse effects of medications and health care interventions including ITB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021061     DOI: 10.1093/rpd/ncr400

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  8 in total

1.  Thyroid blockade in 123I-mIBG cardiac imaging: A common sense approach.

Authors:  Arnold F Jacobson
Journal:  J Nucl Cardiol       Date:  2015-05-14       Impact factor: 5.952

Review 2.  The Iodine Rush: Over- or Under-Iodination Risk in the Prophylactic Use of Iodine for Thyroid Blocking in the Event of a Nuclear Disaster.

Authors:  Valeria Calcaterra; Chiara Mameli; Virginia Rossi; Giulia Massini; Mirko Gambino; Paola Baldassarre; Gianvincenzo Zuccotti
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

Review 3.  Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed.

Authors:  Christoph Reiners; Rita Schneider
Journal:  Radiat Environ Biophys       Date:  2013-03-09       Impact factor: 1.925

Review 4.  The effects of iodine blocking following nuclear accidents on thyroid cancer, hypothyroidism, and benign thyroid nodules: design of a systematic review.

Authors:  Steffen Dreger; Manuela Pfinder; Lara Christianson; Stefan K Lhachimi; Hajo Zeeb
Journal:  Syst Rev       Date:  2015-09-24

5.  Optimal KI Prophylactic Dose Determination for Thyroid Radiation Protection After a Single Administration in Adult Rats.

Authors:  Guillaume Phan; François Rebière; David Suhard; Alexandre Legrand; Floriane Carpentier; Thibaud Sontag; Maâmar Souidi; Jean-René Jourdain; Michelle Agarande; Valérie Renaud-Salis
Journal:  Dose Response       Date:  2017-12-13       Impact factor: 2.658

6.  Quantitative assessment of preventive behaviors in France during the Fukushima nuclear crisis.

Authors:  Pascal Crépey; Mathilde Pivette; Avner Bar-Hen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 7.  The hypothalamic-pituitary-thyroid axis in infants and children: protection from radioiodines.

Authors:  Jeffrey Fisher; Xiaoxia Yang; Curtis Harris; Igor Koturbash; Annie Lumen
Journal:  J Thyroid Res       Date:  2014-05-25

8.  No significant association between stable iodine intake and thyroid dysfunction in children after the Fukushima Nuclear Disaster: an observational study.

Authors:  Y Nishikawa; C Suzuki; Y Takahashi; T Sawano; H Kinoshita; E Clero; D Laurier; G Phan; T Nakayama; M Tsubokura
Journal:  J Endocrinol Invest       Date:  2020-11-18       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.